189 related articles for article (PubMed ID: 9412303)
21. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis.
Wang J; Malik N; Yin M; Smyrk TC; Czaja AJ; Ehman RL; Venkatesh SK
World J Gastroenterol; 2017 Feb; 23(5):859-868. PubMed ID: 28223730
[TBL] [Abstract][Full Text] [Related]
22. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune hepatitis in India: profile of an uncommon disease.
Choudhuri G; Somani SK; Baba CS; Alexander G
BMC Gastroenterol; 2005 Aug; 5():27. PubMed ID: 16098234
[TBL] [Abstract][Full Text] [Related]
24. Acoustic Radiation Force Impulse (ARFI) for Fibrosis Staging in Patients with Autoimmune Hepatitis.
Efe C; Gungoren MS; Ozaslan E; Akbiyik F; Kav T
Hepatogastroenterology; 2015 May; 62(139):670-2. PubMed ID: 26897951
[TBL] [Abstract][Full Text] [Related]
25. Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.
Borssén ÅD; Palmqvist R; Kechagias S; Marschall HU; Bergquist A; Rorsman F; Weiland O; Verbaan H; Nyhlin N; Nilsson E; Werner M
Medicine (Baltimore); 2017 Aug; 96(34):e7708. PubMed ID: 28834875
[TBL] [Abstract][Full Text] [Related]
26. How reversible is hepatic functional impairment in autoimmune hepatitis?
Coverdale SA; Field J; Farrell GC
J Gastroenterol Hepatol; 2003 Apr; 18(4):371-5. PubMed ID: 12653884
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis.
Beyazit Y; Efe C; Tanoglu A; Purnak T; Sayilir A; Taskıran I; Kekilli M; Turhan T; Ozaslan E; Wahlin S
Scand J Gastroenterol; 2015 Feb; 50(2):204-10. PubMed ID: 25495215
[TBL] [Abstract][Full Text] [Related]
28. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
Twaddell WS; Lefkowitch J; Berk PD
Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
[TBL] [Abstract][Full Text] [Related]
29. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation.
Muretto P; Angelucci E; Lucarelli G
Ann Intern Med; 2002 May; 136(9):667-72. PubMed ID: 11992302
[TBL] [Abstract][Full Text] [Related]
30. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
Ngu JH; Gearry RB; Frampton CM; Stedman CA
Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
[TBL] [Abstract][Full Text] [Related]
31. Reversal of liver cirrhosis in autoimmune hepatitis.
Shah AM; Malhotra A; Kothari S; Baddoura W; Depasquale J; Spira R
Hepatogastroenterology; 2011; 58(112):2115-7. PubMed ID: 22234080
[TBL] [Abstract][Full Text] [Related]
32. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis.
Larsen FS; Vainer B; Eefsen M; Bjerring PN; Adel Hansen B
World J Gastroenterol; 2007 Jun; 13(23):3232-6. PubMed ID: 17589903
[TBL] [Abstract][Full Text] [Related]
33. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis.
Czaja AJ; Carpenter HA
J Hepatol; 2004 Apr; 40(4):646-52. PubMed ID: 15030981
[TBL] [Abstract][Full Text] [Related]
34. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characteristics of autoimmune hepatitis in 11 children].
Lu Y; Wang XH; Wang JS
Zhonghua Er Ke Za Zhi; 2010 Oct; 48(10):758-63. PubMed ID: 21176485
[TBL] [Abstract][Full Text] [Related]
36. Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
Soares JC; Borgonovo A; Maggi DC; Pasinato AP; Ramos FG; Dantas-Corrêa EB; Schiavon LL; Narciso-Schiavon JL
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):138-47. PubMed ID: 27091035
[TBL] [Abstract][Full Text] [Related]
37. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
[TBL] [Abstract][Full Text] [Related]
38. Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis.
Landeira G; Morise S; Fassio E; Ramonet M; Alvarez E; Caglio P; Longo C; Domínguez N
Ann Hepatol; 2012; 11(1):100-6. PubMed ID: 22166568
[TBL] [Abstract][Full Text] [Related]
39. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
40. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
